---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-22-018890"
form_type: "8-K"
ticker: null
cik: "0001821323"
company_name: "Sigilon Therapeutics, Inc."
filed_at: "2022-12-21T23:59:59+00:00"
generated_at: "2026-06-21T01:00:12.924146+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Sigilon Therapeutics receives Nasdaq delisting notice for bid price non-compliance; will request hearing

## Summary
- Nasdaq notified Sigilon on Dec 20, 2022 that its common stock will be delisted from the Nasdaq Global Select Market.
- Delisting stems from failure to maintain minimum $1.00 bid price after 180-day grace period ended Dec 19, 2022.
- Company intends to timely request a hearing before the Nasdaq Hearings Panel, which will stay delisting pending decision.
- No assurance that the Panel will grant continued listing or that Sigilon can regain compliance within any granted period.

## SEC filing metadata
- accession: 0001558370-22-018890
- form_type: 8-K
- cik: 0001821323
- company_name: Sigilon Therapeutics, Inc.
- filed_at: 2022-12-21T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1821323/000155837022018890/0001558370-22-018890-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1821323/000155837022018890/sgtx-20221220x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-22-018890
- JSON: https://secwatch.observer/filing/0001558370-22-018890.json
- Plain text: https://secwatch.observer/filing/0001558370-22-018890.txt

## Key facts
- Listing & Compliance Notices
  Sigilon Therapeutics, Inc. received a nasdaq delisting notice notice regarding minimum bid price (rules 5450(a)(1)).
  - Exchange: nasdaq
  - Notice: delisting notice
  - Deficiency: minimum bid price
  - Rules: 5450(a)(1)
  source text: December 20, 2022, the Company received notice from the Staff indicating that the Staff had determined to delist the Company’s securities from The Nasdaq Global Select Market based upon the Company’s continued non-compliance with the $1.00 bid price requirement unless the Company timely requests a hearing before the Nasdaq Hearings Panel (the “Panel”). The Company intends to timely request a hearing before the Panel, which request will stay any further action by the Staff pending the Panel’s decision. The hearing request submitted by the Company would also stay the suspension of securities unt
  evidence_url: https://www.sec.gov/Archives/edgar/data/1821323/000155837022018890/0001558370-22-018890-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.